WebAt 6 months, 465 of 925 patients (50%) in the hypothermia group had died, as compared with 446 of 925 (48%) in the normothermia group (relative risk with hypothermia, 1.04; 95% … WebDec 3, 2024 · The 2013 TTM trial randomized 939 patients who suffered shockable or non-shockable cardiac arrest to TTM with goal of 33°C or the more normothermic 36°C in an …
About The Study TTM2 - TTM2-trial
WebOct 26, 2024 · The TTM2 trial subgroup of individuals, with a nonshockable initial rhythm, had the same relative risk of poor neurological function with targeted hypo‐ and … WebJun 17, 2024 · The TTM2 trial was larger (containing nearly 2,000 patients) and more aggressive at challenging the status quo (comparing hypothermia at 33C to merely fever … ashibah altura
Home [criticalcarereviews.com]
WebJun 15, 2024 · The intervention was 33°C for both the TTM and TTM2 trials. Similarly, a normothermic strategy was a applied as the comparator in both trials: a target temperature of 36°C was used as the control intervention in the TTM trial, and the control intervention was maintenance of normothermia with treatment of fever (≥37.8°C) in the TTM2 trial. 6,8 WebJun 24, 2024 · Michel R. Le May. TTM2 enrolled 1,900 adults with coma after OHCA of presumed cardiac or unknown cause, randomizing them to hypothermia at 33°C followed by controlled rewarming or normothermia at ≥ 37.8°C with early treatment of fever. Nearly all (95%) of the hypothermia group underwent cooling with a device, though nearly half (46%) … WebMar 1, 2024 · Historically, the results of 2 randomised controlled trials published in 2002 in the New England Journal of Medicine demonstrated a significant advantage of therapeutic hypothermia by reducing mortality by 25% and poor neurologic outcome by 27%. 7, 8, 17 The Hypothermia After Cardiac Arrest (HACA) trial randomised 275 patients to normothermia … ashiap man 2022